Diabetes is serious medical ailment, in which there is a lack of insulin produced in the body, or even if it is produced, the body is not absorbing it properly. According to a recent report by Transparency Market Research (TMR), the global Diabetes Drugs Market is expected to project a steady CAGR of 3.6% within the forecast period from 2017 to 2025. In 2016, the global diabetes market was valued around worth US$43.1 bn, which is anticipated to grow around a value of US$58.4 bn by the end of forecast period.
The global diabetes drugs market is predicted to display steadfast growth in the near future. Increasing incidence of diabetes due to sedentary lifestyle coupled with consumption of high calorie food stokes demand for therapeutics for diabetes. Growing geriatric population globally susceptible to age-related medical conditions such as diabetes and blood pressure is also boosting the diabetes drugs market. Research and development initiatives for the introduction of improved drugs is also accentuating the growth of diabetes drugs market.
Besides these, some more factoring propelling the demand in global diabetic drugs market is the availability of comparatively more efficient products, with time. This is because of the consistent efforts by research institution and manufacturers towards the direction. Another change in the global market are the significant sales of diabetic drugs via pharmacies in the hospitals. Other distribution channels that project improved sales are online pharmacies and retail pharmacies.
Request to View Sample of Report -
Recently, the FDA is organizing a meeting of experts to have a discussion on what types of studies it needs to have in order to figure out if diabetes drugs are effective for the heart, or it has adverse effects. The decade old controversies regarding the unsafe medications, has become the present requirement in FDA. It states that firms will first have to prove the facts that the new drugs are not harmful for the heart, and next take up a study to figure out whether it helps in prevention of heart attacks and related heart ailments. The current director of the Division of Metabolism and Endocrinology Products, William Chong, stated that they have currently eight trials being conducted under the supervision. And none of them has resulted in additional cardiovascular threats due to any studies being carried out.
Among the types of diabetes, type 2 dominates the market with highest share globally, owing to its increasing prevalence. Increase in people suffering from obesity in urban cities, rise in disposable income, and better healthcare facilities are contributing in the Rapid rate of growth of obesity in the urban population, improving healthcare facilities, and rising disposable income are supporting the growth of type 2 diabetes in the market.
Comments
Post a Comment